LabVantage Announces New CEO

Publication
Article
In the Lab eNewsletterPharmaceutical Technology's In the Lab eNewsletter 04-07-2021
Volume 16
Issue 4

Mikael Hagstroem has been named as the company’s new CEO.

LabVantage Solutions, a laboratory informatics solutions and services provider, announced on March 25, 2021 that it has named Mikael Hagstroem as its new CEO.

Before taking on his new role, Hagstroem served as CEO and president at MetricStream, an independent provider of governance, risk, and compliance products and solutions; partner at McKinsey & Company and chief operating officer of McKinsey Analytics; and executive vice-president of the SAS Institute and president of SAS International, LabVantage said in a company press release. Additionally, Hagstroem is currently on the board of advisors of the Artificial Intelligence (AI) Forum and has served as chair of the World Economic Forum’s Global Agenda Council on Data-Driven Development, as a member of the executive committee of the US Council for International Business, and as an executive board member of the Atlantic Council.

“[Hagstroem] embodies the sense of purpose and passion required to tackle big goals and the expertise to achieve them,” said Purnendu Chatterjee, chairman of LabVantage Solutions, in the press release. “He is an accomplished business leader who has built innovative data-based enterprises across a range of industries. He is a visionary strategist who understands the transformational potential of advanced technologies and translates them into actionable business initiatives. An inspired leader, [Hagstroem] is committed to accelerating the use of new tools such as analytics and AI to address urgent global problems. We are thrilled to welcome him to LabVantage and excited at the prospect of what we can accomplish together.”

“LabVantage brings the Fourth Industrial Revolution–characterized as a range of new technologies that are fusing the physical, digital, and biological worlds and impacting all disciplines, economies, and industries–to the lab, and I am honored to take the helm,” Hagstroem added in the press release.

Source: LabVantage

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content